Cell & Tissue Preservation Market Size, Trends & Growth [2030]
The global Cell & Tissue Preservation market gathered revenue around USD 4.6 billion in 2021 and market is set to grow USD 10.1 billion by the end of 2030 and is estimated to expand at a modest CAGR of 11.7% during the prediction period 2022 to 2030.
Cell & tissue preservation must be maintained at appropriate temperatures to preserve integrity of the tissue. The receiving facility is responsible for maintaining records; documenting that allograft tissue is maintained at adequate environmental requirements during transportation and stored as per the manufacturer’s recommendations for the specific tissue.
The current methods of cell & tissue preservation involve freeze-drying, deep-freezing, and cryopreservation. Each of these techniques could be utilized for storage of ligament and meniscal allografts. Deep-freezing is a highly common preservation method for ligament and meniscal allografts, entailing simply freezing the tissue to −80°C. The grafts could be preserved for 3 to 5 years. In the freeze-drying process, moisture is removed from the tissue and the graft is vacuum packaged. It could be stored at room temperature for 3 to 5 years; however, it requires rehydration before implantation. Deep-freezing and freeze-drying allograft tissue reduces immunogenicity by killing antigen-bearing cells. Cryopreservation is a process of controlled-rate freezing with extraction of cellular water by means of glycerol and dimethyl sulfoxide. This process preserves some cells and provides a 10-year shelf life.
Increase in Healthcare Expenditure
The increase in healthcare expenditure is estimated to further allow access to quality healthcare and advanced products that include biopreservation facilities, thereby broadening growth prospects. Additionally, gene banks, hospitals, and biobanks that are significant end users of the market, are encouraging most players to develop technologically advanced biopreservation products to enhance patient outcomes. The presence of government healthcare initiatives that provide funds, grants, and contracts for research has fueled R&D activities deployed by various companies. This, in turn, has boosted the scope for adoption of advanced bio-preservation services, which, in turn, is anticipated to fuel the penetration rate during the forecast period.
Rising R&D investments by companies and research communities to improve their capabilities and render efficient products & services are estimated to further create opportunities. For instance, the establishment of the Cooperative Human Tissue Network (CHTN), which addressed the operational dimension of bio-banking, exemplifies consistent efforts by the research community.
Report Scope of the Cell & Tissue Preservation Market
|
Report Coverage |
Details |
|
Market Size by 2030 |
USD 10.1 billion |
|
Growth Rate from 2022 to 2030 |
CAGR of 11.7% |
|
Largest Market |
North America |
|
Fastest Growing Market |
Asia Pacific |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2030 |
|
Segments Covered |
Type, Application, Product, Region |
|
Companies Mentioned |
Thermo Fisher Scientific, Inc., Lonza, BD, Merck KGaA, Cytiva, Agilent Technologies, Inc., Avantor, Inc., FUJIFILM Irvine Scientific, BioLifeSolutions Inc., AMSBIO, Princeton CryoTech, STEMCELL Technologies Inc., LGC SeraCare, Corning Incorporated, and CellGenix GmbH. |
Market Segmentation: Cell & Tissue Preservation Market
Some of the prominent players in the Cell & Tissue Preservation Market include:
Segments Covered in the Report
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Points Covered in Cell & Tissue Preservation Market Study:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Cell & Tissue Preservation Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cell & Tissue Preservation Market Analysis and Forecast, 2017–2030
5. Key Insights
5.1. Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.)
5.2. COVID-19 Pandemic Impact on Industry (value chain and short-/ mid-/ long-term impact)
5.3. Process Analysis
5.4. Top companies operating in Market Space
5.5. Applications of cell & tissue culture in drug development
5.6. Technological Advancements
6. Global Cell & Tissue Preservation Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2030
6.3.1. Cells
6.3.1.1. Mammalian Cells
6.3.1.2. Others (microorganisms and plant cells)
6.3.2. Tissues
6.3.2.1. Blood
6.3.2.2. Bone
6.3.2.3. Soft Tissues
6.3.2.4. Skin
6.3.2.5. Others
6.4. Global Cell & Tissue Preservation Market Attractiveness, by Type
7. Global Cell & Tissue Preservation Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2030
7.3.1. Therapeutics
7.3.2. Research & Development
7.3.3. Drug Discovery
7.3.4. Others (Cosmetics and Clinical trials)
7.4. Global Cell & Tissue Preservation Market Attractiveness, by Application
8. Global Cell & Tissue Preservation Market Analysis and Forecast, by Product
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2030
8.3.1. Equipment
8.3.1.1. Freezers
8.3.1.2. Thawing Equipment
8.3.1.3. Refrigerators
8.3.1.4. Storage Systems
8.3.1.5. Others
8.3.2. Bio preservation media
8.3.2.1. Home-brew media
8.3.2.2. Pre-formulated media
8.3.3. Software
8.4. Global Cell & Tissue Preservation Market Attractiveness, by Product
9. Global Cell & Tissue Preservation Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2030
9.3.1. Biobanks
9.3.2. Hospitals
9.3.3. Others
9.4. Global Cell & Tissue Preservation Market Attractiveness, by End-user
10. Global Cell & Tissue Preservation Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Cell & Tissue Preservation Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Cell & Tissue Preservation Market Attractiveness, by Region
11. North America Cell & Tissue Preservation Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2030
11.2.1. Cells
11.2.1.1. Mammalian Cells
11.2.1.2. Others (microorganisms and plant cells)
11.2.2. Tissues
11.2.2.1. Blood
11.2.2.2. Bone
11.2.2.3. Soft Tissues
11.2.2.4. Skin
11.2.2.5. Others
11.3. North America Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2030
11.3.1. Therapeutics
11.3.2. Research & Development
11.3.3. Drug Discovery
11.3.4. Others (Cosmetics and Clinical trials)
11.4. North America Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2030
11.4.1. Equipment
11.4.1.1. Freezers
11.4.1.2. Thawing Equipment
11.4.1.3. Refrigerators
11.4.1.4. Storage Systems
11.4.1.5. Others
11.4.2. Bio preservation media
11.4.2.1. Home-brew media
11.4.2.2. Pre-formulated media
11.4.3. Software
11.5. North America Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2030
11.5.1. Biobanks
11.5.2. Hospitals
11.5.3. Others
11.6. North America Cell & Tissue Preservation Market Value Forecast, by Country, 2017–2030
11.6.1. U.S.
11.6.2. Canada
11.7. North America Cell & Tissue Preservation Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Application
11.7.3. By Product
11.7.4. By End-user
11.7.5. By Country
12. Europe Cell & Tissue Preservation Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2030
12.2.1. Cells
12.2.1.1. Mammalian Cells
12.2.1.2. Others (microorganisms and plant cells)
12.2.2. Tissues
12.2.2.1. Blood
12.2.2.2. Bone
12.2.2.3. Soft Tissues
12.2.2.4. Skin
12.2.2.5. Others
12.3. Europe Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2030
12.3.1. Therapeutics
12.3.2. Research & Development
12.3.3. Drug Discovery
12.3.4. Others (Cosmetics and Clinical trials)
12.4. Europe Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2030
12.4.1. Equipment
12.4.1.1. Freezers
12.4.1.2. Thawing Equipment
12.4.1.3. Refrigerators
12.4.1.4. Storage Systems
12.4.1.5. Others
12.4.2. Bio preservation media
12.4.2.1. Home-brew media
12.4.2.2. Pre-formulated media
12.4.3. Software
12.5. Europe Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2030
12.5.1. Biobanks
12.5.2. Hospitals
12.5.3. Others
12.6. Europe Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2030
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Cell & Tissue Preservation Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Application
12.7.3. By Product
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Cell & Tissue Preservation Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2030
13.2.1. Cells
13.2.1.1. Mammalian Cells
13.2.1.2. Others (microorganisms and plant cells)
13.2.2. Tissues
13.2.2.1. Blood
13.2.2.2. Bone
13.2.2.3. Soft Tissues
13.2.2.4. Skin
13.2.2.5. Others
13.3. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2030
13.3.1. Therapeutics
13.3.2. Research & Development
13.3.3. Drug Discovery
13.3.4. Others (Cosmetics and Clinical trials)
13.4. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2030
13.4.1. Equipment
13.4.1.1. Freezers
13.4.1.2. Thawing Equipment
13.4.1.3. Refrigerators
13.4.1.4. Storage Systems
13.4.1.5. Others
13.4.2. Bio preservation media
13.4.2.1. Home-brew media
13.4.2.2. Pre-formulated media
13.4.3. Software
13.5. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2030
13.5.1. Biobanks
13.5.2. Hospitals
13.5.3. Others
13.6. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2030
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Cell & Tissue Preservation Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Application
13.7.3. By Product
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Cell & Tissue Preservation Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2030
14.2.1. Cells
14.2.1.1. Mammalian Cells
14.2.1.2. Others (microorganisms and plant cells)
14.2.2. Tissues
14.2.2.1. Blood
14.2.2.2. Bone
14.2.2.3. Soft Tissues
14.2.2.4. Skin
14.2.2.5. Others
14.3. Latin America Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2030
14.3.1. Therapeutics
14.3.2. Research & Development
14.3.3. Drug Discovery
14.3.4. Others (Cosmetics and Clinical trials)
14.4. Latin America Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2030
14.4.1. Equipment
14.4.1.1. Freezers
14.4.1.2. Thawing Equipment
14.4.1.3. Refrigerators
14.4.1.4. Storage Systems
14.4.1.5. Others
14.4.2. Bio preservation media
14.4.2.1. Home-brew media
14.4.2.2. Pre-formulated media
14.4.3. Software
14.5. Latin America Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2030
14.5.1. Biobanks
14.5.2. Hospitals
14.5.3. Others
14.6. Latin America Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2030
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Application
14.7.3. By Product
14.7.4. By End-user
14.7.5. By Country
15. Middle East & Africa Cell & Tissue Preservation Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2030
15.2.1. Cells
15.2.1.1. Mammalian Cells
15.2.1.2. Others (microorganisms and plant cells)
15.2.2. Tissues
15.2.2.1. Blood
15.2.2.2. Bone
15.2.2.3. Soft Tissues
15.2.2.4. Skin
15.2.2.5. Others
15.3. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2030
15.3.1. Therapeutics
15.3.2. Research & Development
15.3.3. Drug Discovery
15.3.4. Others (Cosmetics and Clinical trials)
15.4. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2030
15.4.1. Equipment
15.4.1.1. Freezers
15.4.1.2. Thawing Equipment
15.4.1.3. Refrigerators
15.4.1.4. Storage Systems
15.4.1.5. Others
15.4.2. Bio preservation media
15.4.2.1. Home-brew media
15.4.2.2. Pre-formulated media
15.4.3. Software
15.5. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2030
15.5.1. Biobanks
15.5.2. Hospitals
15.5.3. Others
15.6. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2030
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Cell & Tissue Preservation Market Attractiveness Analysis
15.7.1. By Type
15.7.2. By Application
15.7.3. By Product
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Share Analysis, by Company (2019)
16.2. Company Profiles
16.2.1. Thermo Fisher Scientific, Inc.
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Product Portfolio
16.2.1.3. SWOT Analysis
16.2.1.4. Strategic Overview
16.2.2. Lonza
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Product Portfolio
16.2.2.3. SWOT Analysis
16.2.2.4. Strategic Overview
16.2.3. BD
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Product Portfolio
16.2.3.3. SWOT Analysis
16.2.3.4. Strategic Overview
16.2.4. Merck KGaA
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Product Portfolio
16.2.4.3. SWOT Analysis
16.2.4.4. Strategic Overview
16.2.5. Cytiva
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Product Portfolio
16.2.5.3. SWOT Analysis
16.2.5.4. Strategic Overview
16.2.6. Agilent Technologies, Inc.
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Product Portfolio
16.2.6.3. SWOT Analysis
16.2.6.4. Strategic Overview
16.2.7. Avantor, Inc.
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Product Portfolio
16.2.7.3. SWOT Analysis
16.2.7.4. Strategic Overview
16.2.8. FUJIFILM Irvine Scientific.
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Product Portfolio
16.2.8.3. SWOT Analysis
16.2.8.4. Strategic Overview
16.2.9. BioLifeSolutions Inc.
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Product Portfolio
16.2.9.3. SWOT Analysis
16.2.9.4. Strategic Overview
16.2.10. AMSBIO
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Product Portfolio
16.2.10.3. SWOT Analysis
16.2.10.4. Strategic Overview
16.2.11. Princeton CryoTech
16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.11.2. Product Portfolio
16.2.11.3. SWOT Analysis
16.2.11.4. Strategic Overview
16.2.12. STEMCELL Technologies Inc.
16.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.12.2. Product Portfolio
16.2.12.3. SWOT Analysis
16.2.12.4. Strategic Overview
16.2.13. LGC SeraCare
16.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.13.2. Product Portfolio
16.2.13.3. SWOT Analysis
16.2.13.4. Strategic Overview
16.2.14. Corning Incorporated
16.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.14.2. Product Portfolio
16.2.14.3. SWOT Analysis
16.2.14.4. Strategic Overview
16.2.15. CellGenix GmbH
16.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.15.2. Product Portfolio
16.2.15.3. SWOT Analysis
16.2.15.4. Strategic Overview
16.2.16. Others
16.2.16.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.16.2. Product Portfolio
16.2.16.3. SWOT Analysis
16.2.16.4. Strategic Overview
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers